Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

New Kink in the Link Between GLP-1 Drugs and Cognition

New Kink in the Link Between GLP-1 Drugs and Cognition
ShareXFacebook

(MedPage Today) -- Adults whose type 2 diabetes was treated with GLP-1 receptor agonists were more than likely to develop cognitive impairment over 10 years than their counterparts not treated with GLP-1 agents, a propensity-matched retrospective...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement